Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-24, Stock:JNJ, The news for the past five days is as follows:
2018-01-17: NEWS1: U.S. court invalidates patent on J&J cancer drug Zytiga.NEWS2: &quot;Fast Money&quot; final trades: JNJ, INTC and more.NEWS3: Johnson & Johnson Issues Statement on ZYTIGA® Inter Partes Reviews.NEWS4: 7 More Dividend Stocks Benefiting From the Tax Cut.NEWS5: No More Tears: Johnson & Johnson Is Still in an Uptrend and Keeping Me Humble.NEWS6: Ortho-Clinical Diagnostics SA -- Moody's affirms Ortho-Clinical's ratings, outlook revised to stable.NEWS7: SPLG, JPM, JNJ, ORCL: ETF Inflow Alert.NEWS8: 7 More Dividend Stocks Benefiting From the Tax Cut.NEWS9: Kyprolis Could Boost Amgen’s Revenue Growth in 2018.NEWS10: 3 Dividend Stocks That Pay Out Over $8 Billion a Year.NEWS11: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for January 18, 2018.NEWS12: Johnson & Johnson Aims to Start 2018 Healthy.NEWS13: 3 Dividend Stocks That Pay Out Over $8 Billion a Year.NEWS14: Johnson & Johnson Aims to Start 2018 Healthy.NEWS15: Amgen’s Xgeva Could Witness Revenue Growth in 2018.NEWS16: Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal - sources.
2018-01-18: NEWS1: Can These 4 Large-Cap Drug Stocks Deliver an Encore in '18?.NEWS2: Merck & Co.’s Business Segments and Performance in 3Q17.NEWS3: Can These 4 Large-Cap Drug Stocks Deliver an Encore in &apos;18?.NEWS4: Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label.NEWS5: Merck’s & Co.’s Valuation in January 2018.NEWS6: Market at New Highs: Mega Cap ETFs & Stocks On A Roll.NEWS7: Amgen Gets FDA Nod to Add ENDEAVOR Data on Kyprolis Label.NEWS8: J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What's Up?.NEWS9: J&J (JNJ) Hits New 52-Week High: What's Driving the Stock?.NEWS10: J&J (JNJ) Hits New 52-Week High: What&apos;s Driving the Stock?.NEWS11: J&J (JNJ) to Set Pharma Q4 Earnings in Motion: What&apos;s Up?.NEWS12: How Amgen’s Biosimilars Are Positioned for 2018.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: How Amgen’s Enbrel and Nplate Are Positioned for 2018.NEWS15: U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's BTG.
2018-01-19: NEWS1: Cramer's game plan: Watch individual stocks amid the earn....NEWS2: Jim Cramer breaks down his earning seasons game plan.NEWS3: Upcoming Consumer Earnings Reports to Watch: JNJ, F, SBUX.NEWS4: After Hours Most Active for Jan 19, 2018 :  MSFT, PFE, AAPL, HES, WP, MCHP, GE, JNJ, EBAY, JPM, CSCO, NKTR.NEWS5: Which Biotech Stocks Could Surprise To The Upside On Earnings?.NEWS6: Upcoming Consumer Earnings Reports to Watch: JNJ, F, SBUX.NEWS7: Should You Be Tempted To Sell Johnson & Johnson (NYSE:JNJ) Because Of Its PE Ratio?.NEWS8: Will J&J's (JNJ) Pharma Segment Pull Up its Q4 Earnings?.NEWS9: JNJ’s Recent Spine Business Developments: 4Q17 Expectations.NEWS10: Stocks Move Higher Despite Potential Government Shutdown - U.S. Commentary.NEWS11: Johnson & Johnson’s Pharmaceutical Segment: 4Q17 Estimates.NEWS12: The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis.NEWS13: Merck & Co.’s Diabetes Products in 3Q17.NEWS14: Will J&J&apos;s (JNJ) Pharma Segment Pull Up its Q4 Earnings?.NEWS15: What to Expect from JNJ’s Medical Device Segment in 4Q17?.NEWS16: Johnson & Johnson’s Revenue Estimates for 4Q17.NEWS17: Analysts’ Recommendations for Amgen in January 2018.NEWS18: The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis.NEWS19: JNJ Stock ahead of Its 4Q17 Results: Analyst Recommendations.NEWS20: Johnson & Johnson’s 4Q17 Earnings on January 23: What to Expect.NEWS21: Pharma Stock Roundup: Merck's Keytruda Shines in Study, Priority Review for Kymriah Label Expansion.NEWS22: 6 Drug Stocks With Robust Dividend Payouts.NEWS23: Pharma Stock Roundup: Merck&apos;s Keytruda Shines in Study, Priority Review for Kymriah Label Expansion.NEWS24: AptarGroup Names George Fotiades To Replace Retiring Chairman King Harris.
2018-01-22: NEWS1: These 3 Dow Stocks, This Hot Chipmaker, United Airlines Earnings On Tap: Investing Action Plan.NEWS2: These 3 Dow Stocks, This Hot Chipmaker, United Airlines Earnings On Tap: Investing Action Plan.NEWS3: [$$] Johnson & Johnson's Earnings Are Coming. Here's What to Watch..NEWS4: 3 Stocks Likely to Beat Earnings Estimates This Week.NEWS5: Dow Analyst Moves: JNJ.NEWS6: Healthcare ETFs to Watch As Q4 Earnings Unfold.NEWS7: 3 Stocks Likely to Beat Earnings Estimates This Week.NEWS8: Earnings Preview: Johnson & Johnson And Procter & Gamble Take The Stage Tomorrow Morning.NEWS9: Wynn Resorts, Imax, Johnson & Johnson, Ford and Starbucks as Zacks Bull and Bear of the Day.NEWS10: Analyst Ratings and Recommendations for Johnson & Johnson.NEWS11: Wynn Resorts, Imax, Johnson & Johnson, Ford and Starbucks as Zacks Bull and Bear of the Day.NEWS12: These 2 Developments Could Accelerate Johnson & Johnson's Next Acquisition.NEWS13: What JNJ’s Stock Valuation Tells Us.NEWS14: Johnson & Johnson’s Medical Devices Segment: 4Q17 Estimates.NEWS15: Merck & Co.’s Animal Health Business in 3Q17.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: Johnson & Johnson Is Trading at an All-Time High—What’s Next?.NEWS18: Johnson & Johnson’s Consumer Segment: 4Q17 Estimates.NEWS19: What Analysts Recommend for Bristol-Myers Squibb in January 2018.NEWS20: These 2 Developments Could Accelerate Johnson & Johnson&apos;s Next Acquisition.NEWS21: Sanofi to buy U.S. haemophilia group Bioverativ for $11.6 bln.
2018-01-23: NEWS1: With stocks like FB or P&G, check your bias at the door.NEWS2: Cramer: Check your bias at the door with stocks like Face....NEWS3: Nasdaq Up, Bitcoin Fund Down; Will These 4 Big Cap Techs Beat Apple In 2018?.NEWS4: Stocks End Mixed With Earnings in Focus.NEWS5: Asian Markets Mostly Lower.NEWS6: Nasdaq Leads Stocks Higher As Netflix Sparks Leisure Sector.NEWS7: Johnson & Johnson Stock Dips Despite Q4 Earnings Beat.NEWS8: Close Update: Nasdaq Rally Powered by FANG Stocks.NEWS9: [$$] Johnson & Johnson Results Driven by Pharmaceutical Sales Growth.NEWS10: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,460.29..NEWS11: Dow Closes Wild Tuesday on Sour Note.NEWS12: Netflix and Whirlpool jump while Twitter and J&J fall.NEWS13: Thai Shares May Inch Higher Again On Wednesday.NEWS14: Thai Shares May Inch Higher Again On Wednesday.NEWS15: Health Care Sector Update for 01/23/2018: VYGR,ALT,JNJ,OBLN.NEWS16: Japanese Market Declines.NEWS17: Japanese Market Declines.NEWS18: Johnson & Johnson loses $10.7B after sweeping US tax changes.NEWS19: Where's The Tylenol? J&J Disappoints And Frustrates.NEWS20: Netflix lifts S&P, Nasdaq; J&J, Procter hold Dow in check.NEWS21: Markets Right Now: Tech stocks send indexes mostly higher.NEWS22: Indonesia Bourse Overdue For Consolidation.NEWS23: Indonesia Bourse Overdue For Consolidation.NEWS24: Australian Market Modestly Higher.NEWS25: Australian Market Modestly Higher.NEWS26: Hong Kong Market May Test Resistance At 33,000.NEWS27: Hong Kong Market May Test Resistance At 33,000.NEWS28: Nasdaq Solidly Higher As FANGs Bare Their Teeth Again.NEWS29: China Bourse Called Higher Again On Wednesday.NEWS30: China Bourse Called Higher Again On Wednesday.NEWS31: U.S. appeals court upholds ruling invalidating J&J patent on Remicade.NEWS32: J&J takes $13.6 billion charge related to new U.S. tax law.NEWS33: Win Streak May Continue For Taiwan Stock Market.NEWS34: Win Streak May Continue For Taiwan Stock Market.NEWS35: Health Care Sector Update for 01/23/2018: OBLN,ALT,JNJ.NEWS36: Should J&J Spin Off Its Consumer Business?.NEWS37: Singapore Stock Market May Flirt With 3,600-Point Level.NEWS38: Singapore Stock Market May Flirt With 3,600-Point Level.NEWS39: The new tax law won't change Johnson & Johnson's M&A strategy, CEO says.NEWS40: Johnson & Johnson's guidance impresses before 'disappointing'.NEWS41: Malaysia Shares Draw Flat Lead For Wednesday.NEWS42: Malaysia Shares Draw Flat Lead For Wednesday.NEWS43: Mid-Day Update: Netflix Powers Nasdaq to New Heights.NEWS44: Johnson & Johnson Earnings: When Strong Isn't Strong Enough.NEWS45: Johnson & Johnson takes $13.6 billion charge related to new U.S. tax law.NEWS46: JNJ, PG, TRV, KMB Post Q4 Earnings.NEWS47: J&J takes $13.6 bln charge related to new U.S. tax law.NEWS48: The US is in a baby bust, so diaper makers need a new plan.NEWS49: South Korea Bourse May Add To Its Winnings.NEWS50: South Korea Bourse May Add To Its Winnings.NEWS51: Can Intuitive Surgical Beat Analyst Estimates Again in 4Q17?.NEWS52: Johnson & Johnson Shares Fall Despite Earnings Beat.NEWS53: Don't Expect a Huge J&J Investment Surge.NEWS54: Johnson & Johnson Stock Dips Despite Q4 Earnings Beat.NEWS55: Stocks Trim Early Gains; Netflix Surges On New Subscriber Growth.NEWS56: Dow Movers: PG, TRV.NEWS57: Big Morning for Q4 Earnings: JNJ, PG, TRV, KMB and More.NEWS58: Johnson & Johnson loses $10.7B after sweeping US tax changes.NEWS59: U.S. appeals court upholds ruling invalidating J&J patent on Remicade.NEWS60: Nasdaq, S&P 500 Reach New Record Closing Highs - U.S. Commentary.NEWS61: Nasdaq, S&P 500 Reach New Record Closing Highs - U.S. Commentary.NEWS62: JNJ, PG, TRV, KMB Post Q4 Earnings.NEWS63: J&J takes $13.6 billion charge related to new U.S. tax law.NEWS64: U.S. appeals court invalidates J&J patent on Remicade.NEWS65: Drug companies told to do more to tackle 'superbug' crisis.NEWS66: Big Morning for Q4 Earnings: JNJ, PG, TRV, KMB and More.NEWS67: Dow&apos;s J&J Tops Quarterly Views; Earnings Outlook Helped By Tax Cut.NEWS68: Stocks Trade Mixed, Nasdaq Hits Record as Netflix Soars.NEWS69: 3 Stocks That Feel Like Disney in 1957.NEWS70: Johnson & Johnson Loses Remicade Patent in Appeal Ruling.NEWS71: The Top 5 Johnson & Johnson Shareholders (JNJ).NEWS72: Stocks to Watch: Netflix, J&J, Travelers, Tesla, JPMorgan, Twitter, Apple, P&G, Verizon.NEWS73: Tax Losses Mask Johnson & Johnson&apos;s Fundamental Strength.NEWS74: J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve.NEWS75: Calculating The Intrinsic Value Of Johnson & Johnson (NYSE:JNJ).NEWS76: Johnson & Johnson Takes on $14 Billion Tax Charge With Q4 Earnings.NEWS77: J&J CFO Says Tax Benefits to Spark Innovation Investment.NEWS78: J&J (JNJ) Beats on Q4 Earnings, Misses Sales, Shares Up.NEWS79: Stocks making the biggest moves premarket: JNJ, PG, VZ, JPM, NFLX, ADBE & more.NEWS80: Stocks Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS81: Stocks Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS82: Johnson & Johnson's stock rallies after profit beat expectations, provides upbeat outlook.NEWS83: Johnson & Johnson Reports 2017 Fourth-Quarter Results:.NEWS84: China's Sinocare in deal talks, it says after reported interest in J&J unit.NEWS85: Cancer drugs, Actelion deal boost Johnson & Johnson's revenue, earnings.NEWS86: Canadian Stocks Are Down On NAFTA Concerns - Canadian Commentary.NEWS87: Canadian Stocks Are Down On NAFTA Concerns - Canadian Commentary.NEWS88: Johnson & Johnson Q4 17 Earnings Conference Call At 8:30 AM ET.NEWS89: Johnson & Johnson Q4 17 Earnings Conference Call At 8:30 AM ET.NEWS90: Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View.NEWS91: Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View.NEWS92: Futures Suggest Lower Opening For Wall Street.NEWS93: Johnson & Johnson Q4 Earnings Rise 10%.NEWS94: Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ).NEWS95: 3 Stocks You Can Safely Own Until 2030.

Answer: Rise